A New Neurotech Startup Launches to Rival Sam Altman’s Merge Labs

Merge Labs, a company spun out of Forest Neurotech, is working on developing a brain-computer interface using ultrasound technology. This method measures brain activity indirectly by detecting changes in blood flow, which can cause a slight delay in capturing real-time neural activity. This delay could be challenging for tasks that require immediate responses, like controlling a robotic limb. To address this, Merge Labs plans to use AI models to reduce the lag. The company is conducting its first clinical study in California, using a device similar to headphones to record brain activity. This device aims to be noninvasive, unlike previous methods that required part of the skull to be removed. The goal is to create a practical and accessible interface for both medical and consumer applications, focusing on noninvasive solutions to help people. QUESTION: How might the development of noninvasive brain-computer interfaces change the way we interact with technology in the future? 

Discover more from News Up First

Subscribe now to keep reading and get access to the full archive.

Continue reading